CanniMed Therapeutics
Saskatoon
About CanniMed Therapeutics
CanniMed Ltd. was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis. Currently they operate under the Access to Cannabis for Medical Purposes Regulations(ACMPR) governed by Health Canada. Their history is much deeper, however. From 2000 - 2013 our parent company, Prairie Plant Systems, was the sole supplier to Health Canada of medical cannabis. As a result of over a decade and a half of hands-on experience, we have implemented standard procedures and processes that are in line with pharmaceutical manufacturing standards to ensure consistency of their products for Canadian patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $5.2M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2017)
- Ticker: tsx:CMED
- Website: cannimed.ca
- Phone: +1 18557871577
Industries & Categories
Biotechnology, Cannabis, Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/cannimed-therapeutics-165343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.